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Summary Non-insulin-dependent diabetes mellitus 
(NIDDM) is associated with an increased cardiovas- 
cular risk. Glycaemic ontrol alone is often insuffi- 
cient to control diabetic dyslipidaemia and other car- 
diovascular isk factors associated with NIDDM. 
The present trial was designed to evaluate the effects 
of physical activity as an adjunct o standard iabetes 
therapy on the lipid profile, blood pressure, glycae- 
mic control, weight and body fat. Sixteen well-con- 
trolled (HbAlc 7.5 %) patients with NIDDM partici- 
pated in a regular aerobic exercise training pro- 
gramme at 50-70 % maximal effort over 3 months. 
Thirteen age- and sex-matched patients with 
NIDDM served as a control group. The 3-month in- 
tervention with an increase in physical activity from 
92 (mean+SD)+79 to 246+112min per week 
(p < 0.001) by means of a structured activity pro- 
gramme resulted in significant improvement of plas- 
ma lipids with a 20% decrease in triglycerides 
(p < 0.05), unchanged total cholesterol and increases 
in high-density lipoprotein and high-density lipopro- 
tein-3 subfraction of 23 % (p < 0.001) and 26 % 
(p < 0.001), respectively. Systolic and diastolic blood 
pressure decreased significantly from 138+_ 16 to 
130+17mm Hg (p<0.05) and 88+10 to 80+ 
10 mmHg (p < 0.001), respectively. Resting heart 
rate decreased from 81 + 13 to 74 + 14 beats per min- 
ute (p <0.001), waist-hip circumference ratio de- 
creased from 0.96_+ 0.11 to 0.92 +_ 0.10 (p < 0.001) 
and body fat decreased from 35.3+7.2 to 
33.0 + 8.0 % (p < 0.001). These effects occurred inde- 
pendently of changes in body weight and glycaemic 
control, which did not change during the study. This 
study shows that improvement in physical fitness by 
introducing regular physical exercise as part of the 
treatment programme in patients with NIDDM re- 
sults in a significant amelioration of their cardiovas- 
cular risk profile. [Diabetologia (1995) 38: 1313- 
1319] 
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Diabetes mellitus is associated with a three- to five- 
fold increased risk for coronary heart disease (CHD) 
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[1]. More than 50 % of total mortality in diabetic pa- 
tients is caused by CHD. Abnormalities of plasma lip- 
ids and lipoprotein concentrations are common find- 
ings in diabetic patients, particularly in those with 
poor glycaemic ontrol. Non-insulin-dependent dia- 
betes mellitus (NIDDM) should be considered as 
part of a syndrome of metabolic abnormalities that 
markedly increase the risk for CHD, including dyslip- 
idaemia, insulin resistance, male-type obesity and hy- 
pertension. Thus, the focus of treatment can no long- 
er be on glucose control only, but should be directed 
at correcting these risk factors. Physical training is 
recommended as an adjunct therapy to diet in the 
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Table 1. Baseline characteristics of patients who completed the trial 
Intervention group Control group 
(n= 16) (n= 13) 
Anthropometric and demographic data 
Mean (range) age (years) 
Male/female 
Duration (range) of diabetes (years) 
Body-mass index (kg/m 2) 
Body weight (kg) 
% body fat 
Waist-hip ratio 
History 
Hypertension requiring treatment 
Smokers 
Weekly alcohol intake 0-15 g 
Weekly alcohol intake 15-100 g 
Weekly alcohol intake > 100 g 
Weekly physical activity (min) 
Therapy 
Oral hypoglycaemic agents 
Sulphonylureas (glibenclamide/gliclazide) 
Biguanides (metformin) 
Combination sulphonylureas/biguanides 
c~-glucosidase inhibitors (acarbose) 
Glycaemic control 
HbAlo (%) (normal: 4.0-6.4 %) 
54(42-73) 59(50-79) 
8/8 7/6 
7.1(1-25) 8.7(2-22) 
31.2• 31.3• 
87.3• 86.8• 
35.3• 33.4• 
0.955• 0.979• 
4 6 
3 2 
9 7 
6 4 
1 2 
92 + 79 96 + 75 
10 6 
3 (1/2) 3 (1/2) 
3 1 
2 1 
2 1 
7.5• 7.8• 
Values are mean + SD. p = NS 
management  of N IDDM [21. However,  long-term re- 
sults with exercise regimens have been disappointing, 
largely because of poor  patient compliance [3]. Sev- 
eral reviews have pointed out the potential  for exer- 
cise to improve not only insulin sensitivity, glucose 
tolerance and long-term glycaemic ontrol  in diabetic 
patients, but also to improve the plasma lipid profile, 
b lood pressure and obesity [4, 5]. 
The aim of the present study was to determine the 
changes in glycaemic ontrol,  plasma lipids, particu- 
larly high-density l ipoprotein cholesterol (HDL-C) ,  
HDL-C-subfract ions and triglycerides, blood pres- 
sure, weight and abdominal  fat induced by increasing 
the degree of physical activity in addit ion to standard 
diabetes therapy. 
Patients and methods 
Twenty-one patients from the Diabetes Unit of the University 
Hospital Zurich, aged 42 to 73 years (mean 55.5 years + SD 9,8, 
9 women and 12 men) agreed to participate in a 3-month su- 
pervised exercise training programme. Informed consent was 
obtained and the study was approved by the medical ethics 
committee. The patients were well-controlled on standard 
therapy, including diet and, where appropriate, oral ant• 
betic drugs (Table 1). Exclusion criteria were symptomatic 
CHD, autonomic neuropathy, insulin therapy, and the inability 
to participate in more than 80 % of the training sessions. Six- 
teen patients completed the study (intervention group) and 
five patients dropped out (three were not able to attend the re- 
quired number of sessions and for two the programme was too 
intense). Thirteen age- and gender-matched patients with the 
same duration of diabetes, and similar degree of physical activ- 
ity at baseline served as the control group. The anthropometric 
and demographic data of the patients in the intervention and 
control group at baseline are shown in Table 1. 
Study design. All patients were interviewed during the baseline 
visit. Information was collected on a variety of potential coro- 
nary risk factors, including hypertension, cigarette smoking, di- 
etary intake, socio-economic status, level of physical activity, 
current medication, pre- or postmenopausal tate, oestrogen 
replacement, and alcohol consumption. Average weekly alco- 
hol intake was recorded in grams of ethanol. Three categories 
were defined: less than 15 g ethanol per week, 15 g or more 
but less than 100 g, and more than 100 g per week. 
Analyses were done after a 12-h overnight fast for: blood 
glucose, HbAlc, plasma insulin, C-peptide, total cholesterol, 
triglycerides, HDL-cholesterol (HDL-C), HDL2-cholesterol 
(HDL2-C), HDL3-cholesterol (HDL3-C), apolipoproteins 
A-1 and B, and albuminuria. 
Body weight was measured to the nearest 0.1 kg. Height 
was measured to the nearest cent• Body mass index 
(BMI) was calculated as weight (kg)/height (m)% Waist cir- 
cumference was measured to the nearest 0.5 cent• at the 
level of the umbilicus with the patients tanding and breathing 
normally. Hip circumference was measured to the nearest 0.5 
cent• at the level of the greater trochanters. The average 
of three readings was taken as the measurement of each cir- 
cumference. The readings were done by a single observer. 
Body composition was assessed with a near-infrared inter- 
actance device (Futrex-5000, Futrex Inc., Gaithersburg, MD., 
USA), by using an average of three measurements. This tech- 
nique has been previously described and validated against 
other techniques such as deuterium oxide dilution, skinfold 
thickness and ultrasound and was found to yield reproducible 
results [6]. In our hands intra- and interassay variation was 2.1 
and 2.8 %, respectively. Furthermore we validated near-infra- 
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red interactance against bioelectrical impedance analysis pre- 
viously using the BIA 101/A, a portable bioimpedance analy- 
ser (Akern, RJL System, Detroit, MI., USA), and found a cor- 
relation coefficient of 0.97 (n = 40). 
Blood pressure (BP) was recorded to the nearest 2mm Hg 
after 5 min in the supine position with a mercury sphygmoma- 
nometer. 
Of 16 patients 13 agreed to monitor their BP for 24 h before 
and after the intervention period. BP was measured half-hour- 
ly during the subjects' estimated waking hours of between 
07.00 and 22.00 hours each day and hourly for the remaining 
(overnight) period using an ambulatory sphygmomanometer 
device (SpaceLabs, 90207, Redmond, WA., USA). 
All patients followed a prescribed iabetes diet with 50 % 
carbohydrates, 35 % fat and 15 % protein content. The actual 
daily intake as assessed by a diet diary over a period of 5 days 
was (mean + SD) 1664 + 345 kcal per day with 39 % carbohy- 
drates, 44 % fat and 17 % protein. The average daily choles- 
terol intake was 265 + 104 rag, the fibre intake 17 + 5.3 g and 
the average weekly alcohol intake was 24 + 36 g. Diet and 
medication were kept unchanged throughout the study, with 
the exception that patients treated with sulphonylureas were 
advised to consume xtra carbohydrates when performing ex- 
ercise, in order to avoid hypoglycaemia. 
Protocol of exercise programme. Patients participating in the 
exercise programme were evaluated for physical fitness by a 
step test before and after the intervention. The 3-rain step test 
is a reliable cardiorespiratory test with minimal equipment re- 
quired and was performed as described previously [7]. The 
heart rate was recorded at the end of the test and during the 
first minute while sitting, thus recording the maximal heart 
rate and the rate of recovery. Prior to the intervention period 
the patients underwent a thorough physical examination with 
a stress ECG until exhaustion whereby the maximal heart 
rate was recorded. 
The physician and physical therapist gave oral instructions 
for effective exercise training. Thereafter, physical activity 
was regularly monitored by daily exercise records. The pro- 
bands participated in a weekly supervised training session de- 
signed to induce and maintain physical fitness. The programme 
included aerobic exercise (biking on a stationary bike, rowing, 
skipping rope, walking, jogging, climbing stairs, gymnastics 
and interval training) with heart rate at 50-70 % of the pa- 
tients' maximal effort (according to Schneider and Ruderman) 
[8]. The heart rate was monitored uring the 30-45 rain aero- 
bic training by a heart rate monitor (Polar Target, Model 
#127990, Stamford, CT., USA). The rest of the 90-min pro- 
gramme consisted of warm-up, stretching exercises and post- 
exercise cool-down. Exercise groups and family support were 
strongly encouraged and family members or friends were also 
invited to participate. Exercise was performed under supervi- 
sion of a physician and physical therapist once weekly, and pa- 
tients were encouraged to exercise on an individual basis at 
least 3 times a week for 30-45 rain and record the type and 
time of activity in a log-book. The control group maintained 
their usual evel of activity and diet throughout the study. 
Biochemical nalyses. Glucose was determined by an auto- 
mated hexokinase method (HK, Uni-Kit III, Roche, Basel, 
Switzerland). Plasma lipids were measured in fresh plasma. 
Cholesterol was measured by an enzymatic olorimetric test 
using cholesterase, cholesterol xidase, and aminophenazone 
(Cholesterol PAR MA-kit 100, Roche), and triglycerides were 
determined by a colorimetric reaction with iodonitrotetrazoli- 
um chloride after enzymatic hydrolysis (Triglyceride PAP, 
Uni-Kit III, Roche). HDL-, HDL2- and HDL3-cholesterol 
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were determined using a stepwise precipitation procedure 
with dextran/magnesium chloride and the analytical method 
described above for total cholesterol [9]. This stepwise HDL- 
C precipitation corresponds well with HDL-C subfraction 
analysis by rate zonal ultracentrifugation [10]. Plasma apolipo- 
proteins A-1 and B were determined by nephelometry in a 
Beckman Array Protein System (Beckman Instruments, 
Berkeley, Calif., USA). HbAlc was determined using an 
HPLC system (Biorad Diagnostics Group, Hercules, CA., 
USA). Plasma insulin and C-peptide were measured by radio- 
immunoassay (Diagnostics Products Corporation, Los Ange- 
les, CA., USA). Albuminuria was assessed ina timed overnight 
urine collection by an immunoturbidimetric method (Micro- 
alb, Bayer Diagnostics, Basingstoke, UK) 
Statistical analys& 
Data were analysed with Statistica for Windows software 
(Statsoft, Inc., 1994, Tulsa, Okla., USA). Relations among vari- 
ables of interest were analysed pairwise (before and after inter- 
vention) with the paired Student's t-test for dependent samples 
and, where appropriate, with the Wilcoxon matched pairs test; 
p < 0.05 was considered significant. 
Results 
Physical activity 
The mean time of weekly physical activity increased 
by 267 % of the baseline level, persisted at a high 
level of 317 % and was unchanged in the control 
group (Table 2). Physical fitness as assessed by the 
step test and resting heart rate changed significantly 
in the intervention group only (Table 2). 
Metabolic parameters and body composition 
Significant changes were observed in plasma tipids 
(HDL-C,  HDL3-C,  triglycerides, and apolipopro- 
tein-A1) in the intervention group only. Total HDL-  
C increased by 23 % from (mean + SEM) 1.15 + 0.01 
to 1.42 +_ 0.11 and 1.35 + 0.12 mmol/1 at 6-month fol- 
low-up, respectively (p < 0.001 and p < 0.01). HDL3-  
C increased by 26 % from 0.97 + 0.07 to 1.23 + 0.10) 
and 1.09 + 0.08 mmol/1 (p < 0.001 and p < 0.01), re- 
spectively, while HDL2-C  increased gradually f rom 
0.17 + 0.05 to 0.20 + 0.02 and 0.27 + 0.05 mmol/1 (p = 
0.48 and p = 0.05), respectively. Triglycerides de- 
creased by 20 % from 2.81 + 0.37, to 2.24 + 0.27 and 
2.36 + 0.30 mmol/1 (p < 0.05 and p = 0.01), respec- 
tively. Total cholesterol and low-density l ipoprotein 
(LDL)  remained unchanged (5.6 + 0.2, 5.6 + 0.2, 
5.5 + 0.2 and 3.1 + 0.2, 3.0 + 0.2, 3.1 + 0.2 mmol/1, re- 
spectively (NS), but the cholestero l /HDL-C ratio de- 
creased significantly f rom 5.4 + 0.5 to 4.3 + 0.3 and 
4.5 + 0.4 (p < 0.01 and p < 0.001), respectively 
(Fig.l) .  Apol ipoprotein-A1 increased from 1.51 + 
0.06 to 1.65 + 0.07 and 1.60 + 0.06 g/l, respectively 
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Table 2. Anthropometric data, fitness and metabolic data 
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Intervention group (n = 16) 
Baseline (0) 3 months ($) 6 months (6) 
Control group (n = 13) 
p-value p-value Baseline (0) 3 months (3) 
(0-3) (0-6) 
Anthropometric data (mean _+ SD) 
Body weight (kg) 87.3 _+ 22.3 86.6 _+ 22.2 
Waist-hip ratio 0.955 _+ 0.109 0.924 + 0.103 
% body fat 35.3 -+ 7.2 33.0 + 8.0 
Lean body mass (kg) 55.5 + 11.5 56.6 _+ 10.4 
Fimess (mean _+ SD) 
Weekly activity (rain) 92 + 79 246 -+ 113 
Resting heart rate (bpm) 81 + 3 74 -+ 4 
Maximum heart rate at 
step test 151 + 12 138 _+ 12 
Heart rate (0-60 min) 
(bpm) at step test 136 _+ 16 124 _+ 14 
Metabolic data (mean _+ SEM) 
HbA~ ~ (%) [normal 
value: 4.0-6.4 %] 7.5 + 0.4 7.5 + 0.4 
Fasting plasma glucose 
(mmol/1) 9.0 + 0.8 8.5 + 0.8 
Fasting plasma insulin 
(pmol/l) 149.8 _+ 54.9 121.8 +29.4 
C-peptide (pmol/1) 1025.6 + 150.5 813.8 + 94.3 
Apolipoprotein A1 (g/I) 151 + 0.06 1.65 -+ 0.07 
Apolipoprotein B (g/l) 1.34 + 0.07 1.36 + 0.07 
Low-density lipoprotein 
(mmol/1) 3.12 + 0.23 2.98 + 0.24 
p = NS for control group; ND, not determined 
87.4 -+ 23.7 
0.922 + 0.098 
31.9 -+ 8.6 
58.0 _+ 12.0 
274 _+ 112 
67 _+3 
135 + 11 
121 + 12 
7.5 _+ 0.4 
9.0 _+ 0.7 
179.0 + 39.8 
1243.3 _+ 189.4 
1.60 + 0.06 
1.37 _+ 0.O7 
3.10+0.18 
N:S. N.S. 86.8 + 13.1 86.8 + 12.5 
< 0.001 0.003 0.980 + 0.115 0.980 + 0.110 
< 0.001 < 0.001 33.4 + 7.5 32.9 + 7.3 
< 0.01 < 0.001 54.6 + 7.7 55.1 + 7.9 
< 0.001 < 0.001 91 + 75 94 + 74 
< 0.001 < 0.001 78 + 4 77 + 3 
0.002 < 0.001 ND ND 
0.004 < 0.001 ND ND 
N.S. N.S. 7.8 8.4 
N.S. N.S. 9.8+0.5 9.3+0.7 
N.S. N.S. 108.2 + 19.7 165.0 +32.4 
0.04 N.S. 983.1+ 128.3 1013.9_+ 171.0 
0.02 N.S. 1.60 -+ 0.08 1.53 + 0.07 
N.S. N.S. 1.38 + 0,07 1.30 + 0.09 
N.S. N.S. 3.51 + 0.24 3.19 + 0.29 
(p < 0.05 and NS). No significant changes in fasting 
blood glucose, HbAlc, fasting insulin and C-peptide 
levels could be observed (Table 2). 
No change in body weight was recorded, but body 
fat decreased from (mean + SD) 35.3 + 7.2 to 33.0 + 
8.6 % and 31.9 + 8.6 % at follow-up (p < 0.001) and 
the waist circumference decreased from 103.2 _+ 17.9 
to 100.2 _+ 17.4 and 99.7 + 17.6 cm at follow-up (p < 
0.001), respectively, while hip circumference re- 
mained constant (108.215.2, 108.5 _+ 14.9 and 108.0 + 
15.5 cm). As a consequence the waist-hip ratio 
(WHR)  decreased significantly in the intervention 
group (Table 2). 
Heart rate and blood pressure. A significant reduc- 
tion in the diastolic and systolic BP and resting heart 
rate was observed at clinic readings and with ambu- 
latory-blood pressure monitoring (ABPM).  Systolic 
BP decreased from (mean + SD) 138 + 16 mmHg 
(APBM: 136_+11) to 130+_16.5 (126+6) and to 
128 + 15 (124 + 7) mmHg at follow-up (p < 0.05, 
p = 0.01 and for ABPM p < 0.01), while diastolic BP 
showed a highly significant reduction from 88 ___ 10 
(84 + 8) to 80 + 10 (78 +_ 9) and 77 +_ 6 (76 + 9) at fol- 
low-up, respectively (all p < 0.001) (Fig.2). The ten- 
dency to lower the resting heart rate continued 
throughout the follow-up period (Table 2). 
Influence of  age. Data on plasma lipids, body compo- 
sition, heart rate and BP were subanalysed according 
to the patients' age: _ 55 years (n = 6) and < 55 
years (n = 10, values in parentheses [..]). 
Total HDL-C  increased from (mean+SEM)  
1.15 + 0.08 [1.15 + 0.12] to 1.38 + 0.08 [1.48 + 0.14] 
and 1.33 + 0.10 [1.39 + 0.14] retool/1 at 6-month fol- 
low-up, respectively (p = 0.003 and p < 0.05) 
[p = 0.01 and p = 0.002]. The WHR decreased from 
(mean + SD) 0.960 + 0.063 [0.946 + 0.158] to 
0.927 _+ 0.056 [0.920 _+ 0.151] and 0.930 + 0.05 
[0.909+0.142] at 6-month follow-up, respectively 
(p --- 0.001 and p < 0.05) [p < 0.05 and p < 0.05]. Per- 
centage body fat decreased from 33.9+8.3 
[37.7( + 4.0)] to 30.5 _+ 8.5 [37.3( + 4.9)] and 28.9 + 9.2 
[36.3( + 5.1)]% at follow-up (p < 0.001 and p < 0.01) 
[NS, p < 0.05]. Resting heart rate decreased from 
77+14 [87_+9] to 72+15 [78+11] and 65+13 
[70 + 111 bpm at follow-up, respectively (p < 0.05 and 
p = 0.001 [p < 0.05 and p = 0.01]. Diastolic BP de- 
creased from 90 _+ 11 [86 + 6] to 80 + 10 [80 _+ 10] and 
76 _+ 5 [79 + 7] mmHg at follow-up, respectively 
(p < 0.05) [p < 0.05]. 
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Fig. 1. Lipid profile at baseline, 3 months and 6- 
month follow-up. Values are means + SEM, signifi- 
cant differences from baseline values: * p <_ 0.05, 
9 *p < 0.01, ***p < 0.001 
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Fig.2. Blood pressure at clinic visits and during ambulatory 
blood pressure measurement a baseline, 3 months and at 6- 
month follow-up. Values are means _+ SD, significant differ- 
ences from baseline values: *p _< 0.05, **p _< 0.01, ***p _< 0.001 
Discussion 
It is commonly believed that physical training is not 
a feasible form of therapy for most NIDDM patients 
over 55 to 60 years of age, because of other interfer- 
ing diseases, uch as orthopaedic problems, coronary 
and peripheral artery disease, etc. Furthermore, 
poor long-term compliance was a major problem in 
many studies examining the effects of exercise and 
diet as first-line therapy for NIDDM patients [3, 4, 
11]. Nevertheless we show here that an individualis- 
ed programme with realistic goals, in which the type 
and the setting of the exercise vary, results in good 
compliance and a substantial increase in physical fit- 
ness and that the resulting beneficial effects on ab- 
dominal fat and cardiovascular risk factors were of 
the same magnitude even in older patients. 
Accumulation of abdominal fat is associated with 
a multitude of metabolic omplications such as glu- 
cose intolerance, hyperinsulinaemia, diabetes, and 
with changes in plasma triglyceride and HDL-C con- 
centrations, aswell as hypertension [12]. These chan- 
ges contribute to the cardiovascular risk that is asso- 
ciated with an altered body fat distribution. This 
study shows that even moderate aerobic exercise 
training results in a considerable decrease in whole 
body fat, particularly in a reduction of abdominal 
fat, measured as the WHR. In epidemiological stud- 
ies the WHR has proven to constitute a strong and 
independent cardiovascular risk factor. Besides, 
WHR and visceral fat mass are more closely corre- 
lated to total mortality, mortality from CHD and 
other cardiovascular risk factors than traditional 
measures of adiposity in both men and women [13, 
14]. In our study the decrease in body fat was not ac- 
companied by a loss of body weight, supporting the 
notion that people with large body fat stores are 
somewhat "protected" from losing lean body mass 
as weight is lost. Individuals whose weight is main- 
tained during exercise gain almost twice as much 
lean body mass and lose more fat than do thinner 
persons [15]. 
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The decrease in abdominal fat was paralleled by 
marked changes of the lipid profile in the interven- 
tion group with a highly significant increase in total 
HDL-C by 23 % and in HDL3-C by 26 % together 
with a decrease in triglyceride levels of 20 %. This 
positive effect on plasma lipids was maintained even 
to follow-up at 6 months, with a gradual increase of 
the HDL2-C subfraction. Cross-sectional studies 
have provided evidenc~  for a beneficial effect of 
physical activity that is most consistent for total 
HDL-C and HDL2-C [16]. However, results from 
prospective surveys and intervention studies are 
equivocal. Five of eight exercise trials conducted 
among men [17] showed significant increases in 
HDL-C with exercise. Three of these trials evaluated 
the effect of exercise in women, but no significant dif- 
ferences were reported. A possible source of the dis- 
crepancy between studies is the inconsistent evalua- 
tion of regulators of lipoprotein metabolism other 
than physical activity such as insulin action, body 
composition (body weight, central adipose tissue), al- 
cohol consumption and cigarette smoking. In the pre- 
sent study both the intervention and control group 
were matched with regard to these variables. In the 
non-diabetic population the changes in HDL-C in- 
duced by physical activity were generally thought o 
be due to increases in HDL2-C. There are, however, 
several reports in which HDL3-C was higher in active 
compared with inactive subjects, while there was no 
difference in HDL2-C by activity levels [18. 19]. To 
our knowledge no study has investigated the effects 
of physical activity on HDL-C subfractions in 
NIDDM patients. The present study shows that in un- 
trained insulin-resistant NIDDM patients the initial 
change takes place in the HDL3-C subfraction with 
no changes in the HDL2-C subfraction. However, la- 
ter on - at the 6-month follow-up - when the level of 
physical activity is maintained, HDL2-C starts to in- 
crease and HDL3-C decreases. 
The mechanisms behind the increase in HDL3-C 
by physical activity are not clear. Serum HDL-C lev- 
els are regulated by the lipolytic enzymes, lipoprotein 
lipase (LPL) and hepatic lipase, by cholesterol ester 
transfer protein, and lecithin-cholesterol acyl-trans- 
ferase. Since cholesterol ester transfer protein was 
not changed by physical activity and diet [20], a likely 
explanation would be an initial increase in hepatic li- 
pase activity alone or in association with a decreased 
LPL activity [21, 22]. A low LPL activity is a common 
finding in NIDDM, although exercise is generally 
thought o increase LPL activity. Whatever the rea- 
son, both the HDL2-C and HDL3-C subfractions are 
inversely related to the risk for myocardial infarction 
[23, 24]. Since data in several epidemiological studies 
(e. g., Framingham Heart Study, Multiple Risk Factor 
Intervention Trial) were consistent with a 2-3 % de- 
crease in CHD risk for each 0.03 mmol/1 increase in 
total HDL-C levels [25], the observed increase in to- 
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tal HDL-C levels of 0.27 mmol/1 represents a major 
reduction of the CHD risk. 
In this study a highly significant reduction in dia- 
stolic and systolic blood pressure could be demon- 
strated while measuring blood pressure at clinic visits, 
as well as with ABPM, which is better correlated with 
target-organ damage from hypertension than clinic 
readings [26]. A reduction of both systolic and dias- 
tolic BP to the normal range is particularly important 
in diabetic patients prone to develop nephropathy 
[27]. 
Several studies have shown that increased physical 
activity combined with dietary intervention amelio- 
rates blood glucose level control and can, but does 
not necessarily, result in weight reduction [20, 28, 
29]. In our 3-month trial the increase in physical ac- 
tivity without additional dietary intervention pro- 
duced no significant changes of glycaemic ontrol or 
body weight, which is in accordance with the reported 
difference in the metabolic response to exercise be- 
tween younger and older NIDDM patients. As re- 
viewed by Zierath and Wallberg-Henriksson [4], im- 
proved glycaemic ontrol is generally achieved by 
younger patients with NIDDM, whereas, as in our 
study, the older age groups do not improve glycaemic 
control due to exercise. In addition, beneficial effects 
of exercise programmes are often underestimated, 
because changes in body weight may not necessarily 
reflect improvements in body composition. Also in 
our study, lean body mass increased whil~ the fat 
mass, particularly the abdominal fat, decreased. 
The programme of moderate xercise used in our 
study was acceptable to and generally enjoyed by 
the majority of patients regardless of adiposity, age 
or gender, and may prove to be realistic for a large 
proportion of sedentary people. The substantial im- 
provement in physical fitness and the good compli- 
ance achieved by the exercisers uggest important 
health benefits for both young and older adults with 
NIDDM. Because pharmacological treatment op- 
tions to improve the lipid profiles of individuals with 
diabetes appear to be limited and glycaemic ontrol 
alone is often insufficient to control diabetic dyslip- 
idaemia [30], lifestyle modifications such as physical 
activity remain preferable. Besides, as shown here, 
establishment of a permanent exercise routine im- 
proves the majority of cardiovascular risk factors as- 
sociated with NIDDM or male-type fat distribution 
without he use of additional drug therapy. 
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